0001140361-17-037017.txt : 20170929 0001140361-17-037017.hdr.sgml : 20170929 20170929191924 ACCESSION NUMBER: 0001140361-17-037017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170927 FILED AS OF DATE: 20170929 DATE AS OF CHANGE: 20170929 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Unkart Edward W CENTRAL INDEX KEY: 0001306267 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36830 FILM NUMBER: 171112857 MAIL ADDRESS: STREET 1: 6 VALLEY OAK CITY: PORTOLA VALLEY STATE: CA ZIP: 94028 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200915291 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 200, STE. 2203 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (857) 999-0075 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 200, STE. 2203 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Therapeutics, Inc. DATE OF NAME CHANGE: 20140916 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery, Inc DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery Inc DATE OF NAME CHANGE: 20060105 4 1 doc1.xml FORM 4 X0306 4 2017-09-27 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001306267 Unkart Edward W C/O KALVISTA PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG 200, STE 2203 CAMBRIDGE MA 02139 1 0 0 0 Director Stock Option (Right to Buy) 6.71 2017-09-27 4 A 0 6000 0 A 2027-09-26 Common Stock 6000 6000 D The option vests over a 12 month period: 1/12th on October 27, 2017, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date. /s/Benjamin Palleiko, Attorney-in-Fact 2017-09-29